In order to strengthen its scientific expertise in the treatment of autoimmune diseases and allergies, Neovacs has an experienced and dedicated international scientific committee.

Given the different indications and technologies, Neovacs chose to appoint as a permanent member only Jacques Banchereau, Chairman of the Scientific Advice, with the support of Vincent Serra, Scientific Director. On a regular basis, Neovacs hasa Scientific Advice with international experts depending on the programs and issues selected, to best advise the company in its choices.